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Background: Swelling, pain, and pruritus are the most relevant symptoms after insect bites/
stings. Glucocorticoids and antihistamines are well established in insect sting treatment. 
Bite Away® is a CE-certified medical device of class 2A (noninvasive device intended for 
  administration to the body, which exchanges energy with the patient in a therapeutic manner) 
to reduce swelling, pruritus, and pain after insect bites/stings via non-invasive administration of 
concentrated heat to the skin. We therefore performed a prospective, non-interventional, single-
arm cohort study with 146 volunteers using the visual analog scale (VAS) for insect bites/stings 
to study the reduction of swelling, pruritus, and pain. Demographic data, time from insect sting 
to treatment, number and duration of administrations of concentrated heat, relevant symptoms, 
and the development of a VAS score of swelling, pruritus, and pain on baseline, after 2, 5, and 
10 minutes after administration, were registered.
Results: In total 146 subjects with a mean age of 29.4 ± 20.7 years (range 2–81) were enrolled 
in the study. Ninety-three (63.7%) of the subjects were stung by wasps, 33 (22.6%) of the 
subjects were bitten by mosquitoes, and eight suffered bee stings (5.3%). VAS score swelling 
decreased with statistical significance after the use of Bite Away® from 4 before treatment to 
2 and 1 after 2–5 and 10 minutes, respectively. VAS pain score was 6 before treatment, 2 after 
2 minutes, 1 after 5 minutes, and 0 after 10 minutes (median). VAS pruritus score was only 
available for 52 (35.2%) of the patients. The score decreased from 5 before treatment, to 2 after 
2 minutes, and 0 after 5 and 10 minutes.
Conclusions: Locally administrated concentrated heat leads to fast amelioration of symptoms. 
Usually an absence of symptoms is noticeable 10 minutes after administration. Pain reduction 
is the dominant effect. Compared with alternatives of pruritus and pain treatment after insect 
bites/stings, Bite Away® seems to be the fastest treatment option available.
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Introduction
Swelling, pruritus, and pain are the most relevant symptoms after insect bites/stings.1 
Insects inject a pruritic and/or pain-inducing substance through the epidermis into 
the dermis with their saliva. Allergic reactions are mediated by immunoglobulins that 
target specific antigens in hymenopteran venoms.2 A cascade of activation of histamine 
receptors, followed by neurogene inflammation and edema, erythema, and itching is 
induced.3,4 The prevalence of stinging insect hypersensitivity reactions ranges from 
0.4% to 3.3%5–7 and causes approximately 40 to 100 deaths in the US each year.8,9 Insect 
stings are regularly treated with removal of the stingers,   cooling, and over-the-counter 
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medications. Most common are   topical glucocorticoids, and 
topical or systemic antihistamines. Only in cases of acute 
anaphylaxis is epinephrine an essential drug for emergency 
therapy.8,10,11 Several domestic remedies are used such as 
onions, lemons, saliva, vinegar, or tea tree oil with no evi-
dence for effectiveness in insect sting therapy.
Bite Away® (RIEMSER Arzneimittel AG, Greifswald, 
Germany) is a CE-certified medical device of class 2A (non-
invasive device intended for administration to the body, which 
exchanges energy with the patient in a therapeutic manner) for 
noninvasive administration to the skin to reduce swelling, pru-
ritus, and pain after insect bites/stings. Its   microchip-controlled 
time-heat-constant guarantees a maximum   temperature of 
51°C on a 38.5-mm² gold-covered plate for either 3 or 6 
seconds. Patients individually choose the 3-second button 
(this modus is recommended for anxious people or children) 
or the 6-second button (for anybody else, who can accept the 
duration of treatment), which activates the device.
So far, the effects of concentrated heat on skin after insect 
bites/stings have not been evaluated in any single study. 
We therefore performed a prospective, non-interventional, 
single-arm cohort study with 146 volunteers to study the 
reduction of the visual analog scale (VAS) score of swelling, 
pain, and pruritus after insect bites/stings at German beaches 
and bathing lakes.
Methods
Bite Away® was used in collaboration with the German 
Life Saving Federation and the German Red Cross, section 
Baywatch (Wasserwacht), near bathing lakes and beaches 
in north east Germany. First aiders received a detailed brief-
ing on insect bites/stings management with Bite Away®, 
handling of patient recruitment, and documentation within 
the questionnaire by Lutz Fischer, MD. The observation 
period was from March to October 2009.
Patient selection
Lifeguards on their lifeguard towers or headquarters were the 
first contact persons to treat insect bites/stings. Because Bite 
Away® was used in routine treatment at all study sites, every 
case of an insect sting was enrolled in this study after provi-
sion of a brief explanation to the patient, and the patient giving 
informed consent. There was no selection of subjects with a 
known hypersensitivity to insect bites/stings. A questionnaire 
created in advance was filled in by the first aider. Demographic 
data, time from insect sting to treatment, number and duration 
of administrations, relevant symptoms, and the development 
of VAS for swelling, pruritus, and pain on baseline, 2, 5, and 
10 minutes after administration, were registered. Patients voted 
their individual swelling, pruritus, and pain perception on a 
scale of 0 (none) to 10 (worst imaginable perception). In gen-
eral, children selected the 3-second modus, and adults selected 
the 6-second modus. Depending on the area of the bites/stings 
and the pain perception of the patient, both first aider and 
patient made the decision on the number of treatments.
Data management
An Excel spreadsheet was used for single data entry. The 
structure of the database was adapted from the questionnaire. 
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Figure 1 Frequency and type of insect bite/sting presented for subgroups of male (m) 
and female (f).
Abbreviation: NA, data not available.
Table  1  Symptoms  of  insect  bites/stings  and  mode  of 
administration of Bite Away®
N Frequency (%)
Symptoms
Swelling 108 74
Pain 85 58.2
Pruritus 52 35.6
Dyspnea 2 1.4
Duration of administration
3 seconds 62 42.5
6 seconds 75 51.4
Number of administrations
Once 66 45.2
Twice 36 24.7
Three times 13 8.9
Four times 6 4.1
Five times 5 3.4
NA 20 13.7
Time of administration after insect bite
Within 5 minutes 73 50
Within 15 minutes 106 72.6
More than 1 hour 19 13
NA 15 10.3
Abbreviation: NA, data not available.
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Figure 2 Box-plot of VAS values (on a scale of 10 = maximum severity) of swelling (A), pain (B) and pruritus (C). Results are given for development of symptoms after 2, 
5, and 10 minutes after administration of Bite Away® compared with situation before treatment.
Note: Significantly different P values of Wilcoxon test for comparison between time-points are presented.
Abbreviation: VAS, visual analog scale.
All analyses were performed using SAS software (v 9.2; 
SAS Institute Inc, Cary, NC). Data are expressed as mean, 
standard deviation, median (with interquartile range [IQR]), 
minimum and maximum. Comparisons of VAS scores were 
evaluated using the Wilcoxon test (P , 0.05 was considered 
statistically significant). Statistical tests only have descrip-
tive character. For missing data the last observation carried 
forward method was used.
Results
In total, 146 subjects (67 male, 72 female: for five subjects 
sex was not specified) were enrolled in the study. The mean 
age of the patients was 29.4 ± 20.7 years (range 2–81 years). 
Wasp stings were observed in 93 (63.7%) subjects, mosquito 
stings in 33 (22.6%) subjects, and bee stings in 8 (5.3%) 
subjects (Figure 1). Among all the patients, 108 (74%) had 
swelling, 85 (58.2%) had pain, 84 (57.5%) had erythema 
(reddening of the skin), 52 (35.6%) had pruritus, and two 
(1.4%) had dyspnea. The frequency of symptoms as well as 
the number and duration of Bite Away® administrations are all 
listed in Table 1. In general, patients contacted the lifeguards 
immediately (72.6% of patients within 15 minutes). Although 
swelling was registered for 108 patients, only 95 data sets 
for a VAS score swelling were available. VAS score swell-
ing decreased with statistical significance after the use of 
Bite Away® from 4 before treatment to 2 and 1 after 2–5 
and 10 minutes, respectively (Figure 2A). VAS pain score 
was 6 before treatment, 2 after 2 minutes, 1 after 5 minutes, 
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and 0 after 10 minutes (Figure 2B). By observing the pain 
  perception of the subgroup of patients with wasp bites, an 86% 
reduction of VAS was visible (VAS 7.32 ± 2.45 before treat-
ment to VAS 1.03 ± 1.21; P , 0.0001). Because of the high 
rate of wasp stings, VAS pruritus score was only available for 
52 (35.2%) patients. Stratifying the cohort by age, there was 
a comparable reduction of  VAS score swelling over time for 
children (under 6 years), for adolescents (from 6 to 18 years), 
and for adults (above 18 years) (Figure 3A and B). .
Similarly, a statistical significant decrease of the VAS 
pruritus score was visible from 5 before treatment, to 2 after 
2 minutes, and 0 after 5 and 10 minutes (Figure 2C). The 
decrease of VAS pruritus of the two subgroups’ patients 
with wasps or mosquito bites is comparable. Immediately 
after administration of Bite Away®, there was a significant 
decrease of pruritus whether the patient was stung/bitten by 
a wasp or a mosquito (Figure 4).
Discussion
In this realistic field study, we found a rapid effect after 
Bite Away® administration on VAS score for swelling, pain, 
and pruritus after insect bites/stings. Locally administered, 
concentrated heat, which was recognized by the patients 
as a very short and targeted induction of almost painful 
high   temperature on the skin, led to a fast improvement 
of   symptoms. The symptoms usually faded away after 
10 minutes. Pain reduction, especially for patients with wasp 
stings, was the dominant effect. In the context of a non-
interventional trial in 2009, an alternative topical treatment 
with hydrocortisone also showed a reduction of pain, itch, 
erythema, and swelling after insect stings, but the symptom 
scores decreased slowly over a period of 7 days.12 In an 
experimental setting, 12 atopic dermatitis patients received 
a focal histamine stimulus (20 mC) given by   iontophoresis, 
which was treated with anesthetics   (lidocaine, prilocaine, 
xylocaine) and antihistamines (dimetindene maleate). None 
of the antihistaminic and anesthetic agents reduced the pru-
ritus intensity significantly, when applied for 15 minutes.13 
In contrast, a placebo-controlled, cross-over study in 27 
  mosquito-bite-sensitive subjects showed that prophylacti-
cally given cetirizine 10 mg and ebastine 10 mg daily had 
a significant effect on wheals and pruritus caused by Aedes 
aegypti laboratory mosquitoes.14 When cetirizine 10 mg was 
given prophylactically alone, only VAS scores of pruritus 
differed significantly from the placebo group after 15 and 
60 minutes but not after 12 and 24 hours, in a field study 
in southern Finland, with Aedis communis mosquitos.15 An 
explanation of the mechanism of action for the effective-
ness of concentrated heat in this study can be found in the 
activation and suppression of receptors. A rapid tempera-
ture increase to a maximum of  51°C leads to an activation 
of  transient receptor potential cation channel subfamily V 
member 1 (TRPV1) via C- and Aδ-fibers.16 Midge saliva 
leads to an activation effect comparable to the stimulation 
of the proteinase-activated receptor-2 (PAR-2).17 PAR-2 are 
localized on human skin mast cells. PAR2 activation leads 
to an increase of Ca2+ ions from intracellular calcium stores 
and subsequent histamine release.18 Through the activation 
of TRPV1 by concentrated heat, PAR-2 carrying C-fibers 
may be influenced, suppressing pruritus. Further clinical 
studies showed that itch intensity ratings were significantly 
reduced during repeated noxious heat.19,20
Neither the concentrated heat during treatment, nor the 
number of administrations showed any influence on pain 
perception after 2, 5, and 10 minutes. This could be seen even 
in the stratum of children less than 6 years, who show a much 
0.0
2.5
5.0
V
A
S
 
s
w
e
l
l
i
n
g
Time after treatment (minutes)
10 5 0
10 5 0
0
5
10
<6 years
6–18 years
>18 years
<6 years
6–18 years
>18 years
V
A
S
 
p
a
i
n
Time after treatment (minutes)
A
B
Figure 3 Reduction of swelling (A) and pain (B) is presented as VAS (on a scale 
of 10 = maximum severity) for each time-point of measurement stratified by age 
of patients.
Note: Wilcoxon tests show no statistical differences between subgroups (P . 0.05) 
for 0, 2, 5, and 10 minutes.
Abbreviation: VAS, visual analog scale.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
194
Müller et alClinical, Cosmetic and Investigational Dermatology 2011:4
more pronounced cutaneous pain perception. Interestingly, 
only a few patients needed additional medical treatment. 
Due to the study design, it could not be established for sure 
whether the two female patients suffering from dyspnea had 
an anaphylactic reaction. Nevertheless, the effectiveness of 
Bite Away® in treating severe insect sting anaphylaxis is 
known to the authors from the emergency medical services. 
Controlled studies of the efficacy of the treatment of severe 
insect sting anaphylaxis and the mode of action of Bite Away® 
are still necessary.
Conclusions
Bite Away® reduced VAS scores significantly for swelling, 
pruritus, and pain when used after insect bites/stings in this 
open cohort-study. Compared with alternatives of pruritus 
and pain treatment after insect bites/stings, Bite Away® seems 
to be the fastest treatment option already available.
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Figure 4 The reduction of VAS pruritus (on a scale of 10 = maximum severity) is presented as box-plot stratified for insect type. A highly significant reduction of pruritus is 
visible for mosquitos (A) and wasps (B) before treatment, to 2 minutes after treatment with Bite Away®.
Note: P values of the Wilcoxon test for comparison between time-points are presented, (wasp N = 20; mosquito N = 32).
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